|
PRR11 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.544250E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.379800E-03 |
| Normal-vs-Stage2 |
7.83250000000457E-05 |
| Normal-vs-Stage3 |
1.504100E-03 |
| Normal-vs-Stage4 |
2.980600E-03 |
| Stage1-vs-Stage2 |
1.243260E-03 |
| Stage1-vs-Stage3 |
3.014200E-01 |
| Stage1-vs-Stage4 |
4.600200E-01 |
| Stage2-vs-Stage3 |
1.191220E-01 |
| Stage2-vs-Stage4 |
2.008600E-01 |
| Stage3-vs-Stage4 |
9.652400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.022200E-03 |
| Normal-vs-AfricanAmerican |
3.939400E-03 |
| Normal-vs-Asian |
1.242530E-03 |
| Caucasian-vs-AfricanAmerican |
6.010800E-01 |
| Caucasian-vs-Asian |
3.427000E-01 |
| AfricanAmerican-vs-Asian |
9.832400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.515650E-03 |
| Normal-vs-Female |
1.882270E-03 |
| Male-vs-Female |
6.938200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.937770E-02 |
| Normal-vs-Age(41-60Yrs) |
1.824360E-04 |
| Normal-vs-Age(61-80Yrs) |
1.901330E-03 |
| Normal-vs-Age(81-100Yrs) |
5.016500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.374500E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.083830E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.424200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.324000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.464000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.702200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.062600E-01 |
| Classical-VS-Follicular |
6.975700E-03 |
| Classical-VS-Other |
2.645400E-01 |
| Classical-VS-Normal |
4.316200E-03 |
| Tall-VS-Follicular |
2.747400E-01 |
| Tall-VS-Other |
2.058400E-01 |
| Tall-VS-Normal |
6.100300E-02 |
| Follicular-VS-Other |
6.566000E-01 |
| Follicular-VS-Normal |
1.848030E-04 |
| Other-VS-Normal |
1.084060E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.572500E-04 |
| Normal-vs-N1 |
5.176200E-04 |
| N0-vs-N1 |
5.608000E-01 |
|
|
